We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acadia Pharmaceuticals Inc | NASDAQ:ACAD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.24 | 1.41% | 17.29 | 17.28 | 17.30 | 17.35 | 16.81 | 16.94 | 497,907 | 18:34:27 |
To: All persons or entities who purchased or otherwise acquired common shares of ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) between February 26, 2015 and March 11, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of California. If you purchased or otherwise acquired ACADIA Pharmaceuticals Inc. ("ACADIA") securities between February 26, 2015 and March 11, 2015, your rights may be affected by this action. To get more information at no cost or obligation to you, go to:
HTTP://ZLK.9NL.COM/ACAD-INFOSHEET
The complaint alleges that the Company made false and misleading statements and/or failed to disclose material information regarding the timing of its submission of its New Drug Application to the FDA for Nuplazid.
On March 11, 2015, the Company announced it would delay submitting a New Drug Application for its drug Nuplazid. The Company also noted that Chief Executive Officer Uli Hacksell is retiring. Shares of ACADIA were down more than 20% on intraday trading the following day.
If you suffered a loss in Acadia you have until May 12, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/acadia-pharmaceuticals-acad.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
1 Year Acadia Pharmaceuticals Chart |
1 Month Acadia Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions